Beta Bionics, Inc. (BBNX) Revenue (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Revenue data on file, last reported at $27.6 million in Q1 2026.

• Quarterly Revenue rose 56.62% year-over-year to $27.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110.2 million (up 57.87% YoY) and the FY2025 annual result came in at $100.3 million, up 53.94% from the prior year.
• Revenue eased to $27.6 million in Q1 2026 per BBNX's latest filing, from $32.1 million in the prior quarter.
• The five-year high for Revenue was $32.1 million in Q4 2025, with the low at $12.9 million in Q1 2024.
• Average Revenue over 3 years is $21.4 million, with a median of $20.4 million recorded in 2024.
• The widest YoY moves for Revenue: up 63.14% in 2025, down 36.39% in 2025.
• Beta Bionics' Revenue stood at $20.4 million in 2024, then soared by 57.15% to $32.1 million in 2025, then declined by 13.99% to $27.6 million in 2026.
• Business Quant data shows BBNX's Revenue at $27.6 million in Q1 2026, $32.1 million in Q4 2025, and $27.3 million in Q3 2025.